Ago Research Gmbh
Clinical trials sponsored by Ago Research Gmbh, explained in plain language.
-
New drug duo offers hope for hard-to-treat vulvar cancer
Disease control Recruiting nowThis study tests whether two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with vulvar cancer that has come back, spread, or is too advanced for surgery or radiation. About 42 participants will receive the combination. The main goal is to see how many have thei…
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can drug combo before surgery boost ovarian cancer outcomes?
Disease control Recruiting nowThis phase 2 trial is testing whether giving the drugs olaparib (Lynparza) alone or combined with durvalumab (Imfinzi) before surgery is feasible and safe for people with advanced ovarian cancer. About 60 participants will receive the drugs for a short time before their planned t…
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC